Your account is not claimed yet. You can sign up with ORCID to claim your account.

Pradeep Kumar

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 17

Top Venues

Journal of biomolecular structure & dynamics

RSC advances

Pharmaceuticals (Basel, Switzerland)

Turkish journal of chemistry

Central University of Punjab

Maharshi Dayanand University Rohtak (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central University of Punjab Jul 31o 2015

India

ASSISTANT PROFESSOR :: PHARMACEUTICAL SCIENCES AND NATURAL PRODUCTS

Education History

Maharshi Dayanand University Rohtak Sep 29o 2009 - Jul 11o 2013

India

PHD :: Pharmaceutical Sciences

Publications

Teja Ram, Ankit Kumar Singh, Prateek Pathak, Adarsh Kumar, Harshwardhan Singh, Maria Grishina, Jurica Novak, Pradeep Kumar
Design, one-pot synthesis, computational and biological evaluation of diaryl benzimidazole derivatives as MEK inhibitors. Journal of biomolecular structure & dynamics (2023)
Ankit Kumar Singh, Pankaj Sonawane, Adarsh Kumar, Harshwardhan Singh, Vladislav Naumovich, Prateek Pathak, Maria A Grishina, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas, Amita Verma, Pradeep Kumar
Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022. ACS omega 8 (31) (2023)
Adarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, Harshwardhan Singh, Tanuja Angre, Amita Verma, Habibullah Khalilullah, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Pradeep Kumar
Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents. RSC advances 13 (10) (2023)
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Prateek Pathak, Maria Grishina, Jagat Pal Yadav, Amita Verma, Pradeep Kumar
Metal Complexes in Cancer Treatment: Journey So Far. Chemistry & biodiversity (2023)
Priyanka Bajpai, Ankit Kumar Singh, Shivanada Kandagalla, Phool Chandra, Vimlendu Kumar Sah, Pradeep Kumar, Maria Grishina, Om Prakash Verma, Prateek Pathak
Oxazoline/amide derivatives against M. tuberculosis : experimental, biological and computational investigations. Journal of biomolecular structure & dynamics (2023)
Teja Ram, Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Prateek Pathak, Maria Grishina, Habibullah Khalilullah, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Amita Verma, Pradeep Kumar
MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives. RSC medicinal chemistry 14 (10) (2023)
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria A Grishina, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid M Emwas, Pradeep Kumar
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Adarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, Harshwardhan Singh, Tanuja Angre, Amita Verma, Habibullah Khalilullah, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Pradeep Kumar
Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents. RSC advances 13 (10) (2023)
Ankit Kumar Singh, Adarsh Kumar, Sahil Arora, Raj Kumar, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas, Pradeep Kumar
Current insights and molecular docking studies of HIV-1 reverse transcriptase inhibitors. Chemical biology & drug design (2023)
Avadh Biharee, Arpita Yadav, Kailash Jangid, Yogesh Singh, Kulkarni Swanand Sanjay, Devesh M Sawant, Pradeep Kumar, Suresh Thareja, Akhlesh Kumar Jain
Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations. Journal of biomolecular structure & dynamics (2022)
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Suresh Thareja, Pradeep Kumar
Regulation of thymidylate synthase: an approach to overcome 5-FU resistance in colorectal cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Yogesh Singh, Kulkarni Swanand Sanjay, Pradeep Kumar, Satwinder Singh, Suresh Thareja
Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors. Journal of biomolecular structure & dynamics (2022)
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria A Grishina, Mariusz Jaremko, Abdul-Hamid M Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah, Pradeep Kumar
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Ankit Kumar Singh, Jurica Novak, Adarsh Kumar, Harshwardhan Singh, Suresh Thareja, Prateek Pathak, Maria Grishina, Amita Verma, Jagat Pal Yadav, Habibullah Khalilullah, Vikas Pathania, Hemraj Nandanwar, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Pradeep Kumar
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine-sulfonamide hybrids as selective BRAF V600E inhibitors. RSC advances 12 (46) (2022)
Laxmi Banjare, Yogesh Singh, Sant Kumar Verma, Atul Kumar Singh, Pradeep Kumar, Sabyasachi Senapati, Akhlesh Kumar Jain, Suresh Thareja
Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors. Journal of biomolecular structure & dynamics (2021)
Pradeep Kumar
A review on quinoline derivatives as anti-methicillin resistant Staphylococcus aureus (MRSA) agents. BMC chemistry 14 (1) (2020)
Nivedita Bhardwaj, Diksha Choudhary, Akashdeep Pathania, Somesh Baranwal, Pradeep Kumar
Synthesis and molecular docking studies of quinoline derivatives as HIV non-nucleoside reverse transcriptase inhibitors. Turkish journal of chemistry 44 (6) (2020)

Pradeep Kumar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Pradeep Kumar